Buy now! Experts say 8 stocks to see 22-130% Q1 profit growth

Sat, Jul 06, 2013 at 16:12

| Source:
Share   .   Email   .   Print      

Aurobindo Pharma

Q1FY14 Profit (estimates): Rs 182 crore

YoY jump (estimates): 130.4%

Target: Rs 271

Rating: BUY

Rationale: Aurobindo Pharma is expected to post a net sales growth of 38.7% YoY. The margins are likely to expand to 16.2% vs 10.3% in 1QFY2014, which will lead the net profit of Rs 182cr vs Rs 79cr in 1QFY2014.

Explore Moneycontrol

Copyright © Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of is prohibited.